Instil Bio Reports Q3 Results, Cash Position of $67.1 Million
Instil Bio posted a net loss of $13.0 million for the first nine months of 2026, with its cash position decreasing to $67.1 million and expected to fund operations through 2027.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed